Table 4.
Characteristics | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P values | HR (95% CI) | P values | |
Age | 0.928 (0.386–2.233) | 0.868 | 2.440 | 0.118 |
Gender | 1.857 (0.248–13.910) | 0.547 | 2.856 | 0.091 |
T stage | 8.280 (2.408–28.478) | 0.001* | 5.624 (1.594–19.840) | 0.007* |
N stage | 2.229 (0.910–5.461) | 0.080 | 0.081 | 0.776 |
M stage | 3.935 (1.418–10.917) | 0.009* | 2.744 (0.987–7.629) | 0.053 |
Clinical stage | 6.252 (1.827–21.396) | 0.004* | 0.398 | 0.528 |
Relapse | 3.377 (1.395–8.175) | 0.007* | 2.153 | 0.142 |
Thyroid cartilage invasion | 4.005 (1.634–9.819) | 0.002* | 0.699 | 0.403 |
CD44 | 5.845 (1.936–17.647) | 0.002* | 1.459 | 0.227 |
CD133 | 3.769 (1.436–9.891) | 0.007* | 0.626 | 0.429 |
PLOD2 | 6.720 (2.193–20.588) | 0.001* | 4.559 (1.356–15.325) | 0.014* |
HR hazard ratio, CI confidence interval
* p < 0.05